Human obesity can be viewed as a set of phenotypes that evolve over time in a sequence of stages that need to be precisely measured. Environmental, behavioral, genetic and biological factors interact to cause obesity. This presentation provides a clinical viewpoint on some biological processes that may explain some of the stages in the development of human obesity, its chronic maintenance and occurrence of complications, with a focus on brain structures, genetics, the profound alterations in adipose tissue biology and gut microbiota components. Roux-en-Y gastric bypass surgery is an increasingly effective model to study in this context because it leads to major improvements in glucose and lipid homeostasis and to the amelioration of some systemic inflammatory markers. International Journal of Obesity (2011) 35, S7-S15; doi:10.1038/ijo.2011.141
Although France is frequently considered as a country protected from obesity, the prevalence of obesity has nevertheless increased, as in many developed countries. Obesity in France is estimated to occur in 14.5% of the population aged over 15 . It is estimated that 150 000 French individuals have undergone a bariatric surgical procedure. The progression of bariatric surgery in the country is even more rapid than the progression of obesity. Taking into consideration the population demography, the resource devoted to bariatric surgery is approximately the same in France as in the United States.
Genetic factors barely explain the significant increase in the prevalence of obesity. Social and economic factors such as academic achievement, job title and income correlate with obesity epidemics. Eating habits are crucial, and numerous factors drive increased individual food intake, including availability and palatability of foods, visual and olfactory cues, conviviality, cultural attitudes, work-related eating habits and eating disorders. As in many countries, energy density of available foods and serving sizes influence the risk of obesity. 1 Although physical activity-related energy expenditure is increased in obese compared with lean subjects, the level of physical activity is classically lower in obese compared with lean subjects, and low physical activity levelFand increased sedentary behaviorFis associated with weight gain. On the other hand, increased body weight and obesity result in decreased physical activity, and therefore a complex and circular relationship occurs. 2 We are now in uncharted territory, our traditional model for eating is not relevant to modern lifestyles, and the profound changes in eating habits are not conducive to appropriate nutrition. As a result of changes in clothing, heating and means of transportation, we expend less energy than in past years; there is a decrease in the need for manual work and efforts to obtain food. Increased television-viewing time is usually associated with greater intake of energy-dense high-fat foods. Reduced sleep duration has been associated with obesity. 3 The discovery of a negative association between brown adipose tissue amount and outdoor temperature raises the question of a link between global warming and the worldwide progression of obesity. Although experts raise the point that the 'obesogenic' environment, rather than biology, is the major factor in obesity progression, these factors are not mutually exclusive. 4 More research is needed to examine the environmental stimuli promoting weight gain, and their interaction with biological systems that promote fat storage ( Figure 1 ). For example, stress appears to promote visceral fat gain and inflammation in mice via a mechanism involving the direct action of neuropeptide Y on adipose tissue. 5 Other factors such as pollutants, for example, phthalates and organotins (produced by the plastic industry), interfere with the master regulators of adipogenesis, peroxisome proliferator-activated receptors. Pollutants are not only endocrine disruptors functioning on these receptor system but are also considered as metabolic disruptors. 6 led to increased levels of serum persistent organic pollutants and, within 6 to 12 months, to a significant 15% decrease in total polychlorinated biphenyls. In this study, persistent organic pollutants levels were positively correlated with liver toxicity markers and lipid parameters. Obese subjects with the greater increase in persistent organic pollutants in the blood after weight loss had a delayed improvement of lipid and liver parameters. These new data suggest that in the future, greater attention must be paid to the biological influence of various pollutants being concentrated in adipose tissue, as well as microorganisms such as bacteria, including external and internal bacteria such as the gut microflora, 8 and maybe even viruses. 9 Examples of association between gut microbiota changes and obesity-related bioclinical parameters will be discussed in the closing paragraph of this paper.
Natural history of human obesity: a kinetic history
Body fat accumulation in obese people indicates failure of the body to ensure proper energy homeostasis by failing to adjust for environmental influences, behavior, psychological factors, genetic makeup and neurohormonal status. 10 Although the use of body mass index (BMI) exceeding 30 kg m À2 is convenient to define obesity, this index does not account for body composition (i.e., fat and fat-free mass distribution) and for the natural history of a disease that evolves over time in a sequential manner. Obesity can be considered as a pathological deviation from the physiological evolution of fat mass over the lifetime (early growth, puberty, menopause, age, seasonal variation and aging).
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One may schematically distinguish a 'static phase' when the individual at risk of obesity is weight stable and in energy equilibrium; a 'dynamic weight gain phase' during which weight is gained as a result of positive energy balance with energy intake exceeding expenditure; and an 'obese static phase' when the individual is weight stable again, but at a higher level, and energy balance is regained. Weight fluctuates as a result of efforts to lose weight and return to initial weight. Weight fluctuations ('yoyo' syndrome) correspond to the notion of weight cycling and frequently result in an even greater increase in weight. The resistance to weight loss and propensity to regain weight is a phenotype characterizing chronic obesity. During the onset of obesity, minor energy imbalance can lead to gradual but persistent weight gain over time. The importance of the energy balance equation is well documented. 4, 12 For example, an increase in energy intake of only 100 kcal per day is sufficient to explain the average rate of weight gain in the past decade in the United States. 4 Depending on individual genetic background, behavioral and environmental factors are forces driving energy imbalance, and participate in energy storage in the adipose tissue ( Figure 2 Figure 1 Complexity of obesity. The complex interactions underlying polygenic obesity demonstrate that genetic, social, behavioral and environmental aspects are all factors capable of influencing the obese phenotype. The DNA strand should be interpreted as taking into account both genetic polymorphisms and the conformation of DNA structure (i.e., degree of methylation influenced by epigenetic events). In the future, new environmental factors might be considered as pollutants, as well as gut microbiotia components.
Peripheral and central nervous system dialogues
Neurohormonal circuits convey information about absorptive and postabsorptive periods, energy reserves, nutritional status, sensory inputs and the environment.
14 There has been considerable improvement in the understanding of how neuronal circuitry integrates peripheral signals and regulates energy homeostasis. Hypothalamic structures relay complex networks of anabolic and catabolic effectors. 15 Although the concept of 'feeding' and 'satiety' centers developed in the 1950s proved overly simplistic, it allowed the identification of 'first-order' arcuate nucleus and 'second-order' periventricular nucleus, dorsomedial and ventromedial nuclei and lateral hypothalamic area peptidergic neurones, which have pivotal roles in controlling energy homeostasis. Arcuate nucleus neurones coexpressing proopiomelanocortin-derived alpha-melanocyte-stimulating hormone and 'cocaine-and amphetamine-regulated transcript', both peptides reducing food intake and energy storage, are considered as a part of the 'first-order' catabolic system. Catabolic circuits function by inhibiting the activity of 'first-order' anabolic neurons containing neuropeptide Y/agouti-gene-related peptide and functioning on 'secondorder' neurons located in the periventricular nucleus, ventromedial nuclei, dorsomedial nuclei and lateral hypothalamic ares. Neuropeptide Y and alpha-melanocytestimulating hormone-containing terminals target two distinct 'second-order' lateral hypothalamic neuronal populations, namely the melanin-concentrating hormone and the hypocretins/orexins neurons. 16 The melanocortin 4 receptor (MC4R) and one of its downstream effectors, that is, brain-derived neurotrophic factor are pivotal in relaying information from the leptin (LEP)/melanocortin pathways. 15 The role of these neuronal systems is not restricted to feeding behavior or energy expenditure, but more widely in the control of sleep/wakefulness and general arousal. At the molecular level, progress has been made in the examination of the transcriptional regulators such as signal transducer and activator of transcription 3, Forkhead box protein O1 and signaling pathways (such as phosphatidylinositol-3-kinase/AKT) transmitting information from signals such as LEP and insulin. 14, 15, 17 Since its discovery, the adiposeproduced hormone LEP is described as a master regulator that stimulates the catabolic and inhibits the anabolic Cell modifications have been studied in vitro and a lot is to be understood in vivo in humans and during the life course. Arrows show macrophage accumulation either in the parenchyma or in crown-like structure around moribund adipocytes. It is of particular importance to delineate their precise phenotype; that is, proinflammatory M1 cells may diminish proliferation capacities, whereas an anti-inflammatory M2 state may promote differentiation of preadipocytes. Studies proposed a M2 phenotype of macrophages accumulating in human WAT. 73 Bariatric surgery and adipose tissue K Clément system. 18 Other signals participate in this regulation, including gut-derived hormonal and peptidergic signals (i.e., ghrelin-stimulating appetite, cholecystokinin, peptide YY , incretins, providing satiety signals and oxyntomodulin) or endogenous steroids, and factors such as serotonin or epinephrine. Other substances that increase food intake are alpha2 adrenergic agonists, opioids, the dopaminedependent reward system and endocannabinoids that increase the motivation to eat and contribute to the rewarding system. Neurons are also sensitive to metabolized nutrients (glucose, lipids and amino acids) 15, 19 and inflammatory mediators via chemokines and cytokines. 20 Proopiomelanocortin neurons are responsive to glucose, promoting the release of alpha-melanocyte-stimulating hormone, 21 but become resistant to glucose in mice fed a high-fat diet. The mode of action for peripheral stimuli originating from both the gut/portal vein axis (hormones such as glucagon-like peptides, afferent vagal nerve fibers and portal glucose) and the bloodstream (variations in both nutrients and hormones concentrations, such as insulin and LEP) need to be further explored. The molecular perturbations and adaptations during the natural evolution of obesity in the neuronal system (i.e, neuronal resistance to input signals such as LEP in so-called LEP resistance) 18 still remain to be clearly understood in humans.
Genetic contributors
As emphasized by twin studies, 22 genetic factors confer biological susceptibility on the effects of the environment and individual behavior. 23 Susceptibility may also result from intrauterine or postnatal genetic imprinting. 24 There is a wide spectrum ranging from genetically determined obesity to behaviorally determined obesity, with most individuals containing a mix of these factors (i.e., geneenvironment interaction). On one end of the spectrum, there are genetically linked obese conditions characterized by severe and early-onset obesity associated with various combinations of behavioral (including hyperphagia, foodseeking and impulsive behaviors), developmental, neurosensorial, endocrine disorders and dysmorphic features. The genetic basis of syndromic obesities (e.g., Prader-Willi and Bardet-Biedl) is complex. 23, 25 As naturally occurring mutations and the targeted disruption of genes in mouse models (LEP, LEP receptor, proopiomelanocortin, MC4R, MC3R) were found to have pivotal roles in the same molecular pathway, genes in and associated with the LEP/melanocortin pathway were explored in human cases. Mutations in genes encoding major proteins involved in the LEP/melanocortin pathways indeed explain rare forms of monogenic obesities. 26 MC4R mutations influence early weight gain with various degrees of severity. Admittedly, obesity associated with MC4R mutations is the most common genetic form of obesity. The frequency of hMC4R mutations with in vitro functional consequences is relatively high (1.5-6%) in obese populations of European and North-American origins. Unlike other monogenic obesities with individuals being carriers of homozygous or compound heterozygous mutations, most individuals are heterozygous carriers of mutated hMC4R with an autosomic dominant inheritance, variable expression of obesity with age (i.e., from severe obesity to normal weight in MC4R-mutated carriers) and generational influences (i.e., children are more severely affected than their parents). 23, 26 Although these mutated genes influence unambiguously the dynamics of weight gain in individual carriers, characterizing the impact of genetic determinants on phenotypes of common forms of obesity is more complex. In recent months, vast progress has been made in the understanding of the genetics of common obesity owing to the rapid development of large-scale genetic screening (genome-wide association) in large populations grouped in very large consortiums. 27 These approaches led to the identification of new chromosomal locations with singlenucleotide polymorphisms potentially affecting individual BMI. Large numbers of individuals (30-80 000) were required to reach sufficient power to detect these genetic variants. However, this was sometimes at the expense of taking into account more specific body composition measures and/or other more precise phenotypes. BMI is the more frequently used phenotype, and each variant allele explained a tiny proportion of its variance (from 0.05 to 0.24 BMI unit) with a modest, but graded, impact when variant alleles were combined (reviews in Leibel 28 and in Hofker and 
Pathological alteration of white adipose tissue in chronic obesity
Depending on an individual's genetics, obesity reaches a plateau characterized in part by resistance to weight loss, propensity to weight regain and the appearance of obesity comorbidities. The phenotype, amount and biology of each white adipose tissue (WAT) component are altered in chronic obesity ( Figure 3) . WAT is composed of mature adipocytes, precursors (preadipocytes), endothelial cells, macrophages, mast cells, blood vessels, nerves, lymphatic and connective tissue. 31 In addition to adipocyte metabolic dysfunction (i.e., lipogenesis and lipolysis capacity), 32 cellular stress including inflammation, oxidative damage, 33 endothelial reticulum stress 34, 35 and hypoxia 36 might be biological alterations that attract and retain inflammatory cells in WAT 37 and eventually promote adipocyte insulin resistance.
Bariatric surgery and adipose tissue K Clément
Plasticity of fat cell is illustrated by the capacity of the adipocyte to expand (hypertrophy) owing to an increase in the amount of triglycerides contained in cell droplets. 38 It is believed that beyond a threshold, the cell can no longer enlarge, and that increased fat storage requires an increase in the number of adipocytes (hyperplasia) and adipocyte differentiation. 39 Fat hyperplasia involves the engagement of precursor cells that subsequently differentiate into mature adipocytes via a transcriptional program; this is well established in murine adipocytes. 40, 41 Once differentiated, adipocytes cannot recover their precursor state and remain available for fat storage even after losing weight. The amount of body fat cannot decrease below the level determined by the adipocyte number. The tightly regulated fat cell number is higher in obesity. However, the acquisition of adipocyte number appears to occur mainly from birth to early adulthood and remains constant thereafter. Obese adults are continually replenishing an existing larger pool of adipocytes. Cleverly using the integration of 14C, derived from the nuclear bomb tests in adipocyte genomic DNA, Spalding et al. 42 showed that B10% of adipocytes in adults are renewed annually, regardless of age or BMI.
WAT is an active endocrine and paracrine organ that synthesizes regulators pivotal for body homeostasis, such as LEP, and releases energy substrates (i.e., fatty acids) to other organs when needed. 43 Increased circulating inflammatory molecules and decreased production of insulin-sensitizing hormones, such as adiponectin, are hallmarks of obesity. 44 Whereas hypertrophic adipocytes synthesize inflammatory molecules, 45 low-grade inflammation mainly relates to immune cells accumulating in obese WAT (Figure 3) . Macrophages, neutrophils, 46 lymphocytes, 47 natural killer cells and mast cells are found in human adipose tissue, but their cellular phenotype, kinetics of accumulation and their precise role in the perturbation of WAT biology are still not clear. 48 There are discrepancies between rodent and human data. Macrophages, the most extensively studied cell in WAT, are increased in proportion to the amount of body fat, 37, 49 and are more abundant in visceral than in subcutaneous depots. 50 Further observations in humans suggest that the macrophages accumulating in the adipose tissue have a complex phenotype and that their characterization by 'only' M1 (proinflammatory) and M2 (anti-inflammatory) pattern is probably oversimplistic. Caspar-Bauguil et al. 51 showed the modulation of T-and natural killer cell subtypes in animals fed a high-fat diet. High-fat-diet-induced insulin resistance in rodents was associated with T-lymphocyte infiltration in the visceral depot, a phenomenon preceding macrophage recruitment. 52 Recent data suggest that mast cells are also important immune cells in WAT, as the absence of mast cells in transgenic mice leads to resistance to diet-induced weight gain and improved blood glucose tolerance. 53 The precise role of lymphocytes, natural killer cells and mast cells in WAT in humans needs to be elucidated. Finally, endothelial cells are also important components, with a proinflammatory status in obesity, probably contributing to local inflammation in WAT. 54 The adipose tissue of weight-stable obese subjects showed transcriptomic interactions that demonstrated a strong relationship linking inflammatory processes to extracellular matrix (ECM) remodeling. 48 In morbidly obese subjects, our group showed that interstitial fibrosis accumulates in WAT. 48 Fibrosis can be found in organs (i.e., liver, lung, kidney) of subjects with chronic diseases and low-grade inflammation. This observation was confirmed at the cellular level. WAT inflammation, mainly due to non-adipose cells, leads to major perturbations in preadipocyte biology, particularly the promotion of nuclear factor kappa B-dependent inflammation, ECM component synthesis (such as fibronectin and collagens), as well as the acquisition of migratory properties, increased proliferation and diminished differentiation [55] [56] [57] ( Figure 3 Figure 3 Paracrine cross-talk between macrophages, adipocytes and preadipocytes: local and systemic consequences. It has been proposed in mice that although resident macrophages are of M2 (anti-inflammatory phenotype), macrophages with a proinflammatory phenotype (M1) accumulate in adipose tissue of mice fed a high-fat diet. 74, 75 Macrophages modify the biology of adipocytes and preadipocytes via the local production of adipokines. Tumor necrosis factor has been proposed to mediate some effects. The nuclear factor-kappa B pathway implicated in the primary regulation of inflammatory responses is induced in preadipocyte and adipocytes in the presence of macrophages medium. The Toll-like receptor (TLR4), not only expressed in macrophages but also in adipocytes, are factors leading to the induction or suppression of genes orchestrating the inflammatory response. 76 Free fatty acids produced by adipocytes after adrenergic stimulation are strong inducers of the TLR4/nuclear factor kappa B. Increased adipose-produced fatty acids activate TLR4 perpetuating the inflammatory changes. TLR4 knockout mice are protected from these deleterious effects, especially from insulin resistance induced by lipid infusions.
The dynamics of WAT inflammation, metabolic alteration and ECM remodeling in the progression of human obesity remains unclear (Figure 1 ). Increased interstitial fibrosis in WAT could impair cell-to-cell contact and therefore interfere with cell signaling mechanisms that regulate adipogenesis and metabolic functions of WAT. As such the appearance of fibrosis in the subcutaneous adipose tissue may perturb the adipocyte adipogenic and lipolytic capacity and lead to dysfunction in fat storage eventually because of reduced capacity for adipose tissue expansion. It is well known that the inability to properly store fatty acids in adipose tissue induces ectopic fat depots in the muscle and liver and promotes insulin resistance. 13 Accordingly, the consequence of the modulation of ECM stiffness has been illustrated by cell and mouse studies. The absence of MTP1-MMP, a matrix metalloproteinase, leads to increased rigidity of ECM, diminished adipose tissue expansion and lipodystrophy. 61 In contrast, in genetically obese mice, the deletion of collagen VI, a key component of ECM, favors adipose expansion and decreased inflammation and is associated with an improved metabolic profile. In humans, adipose tissue remodeling and fibrosis are poorly documented. In 2008, Henegar et al. 48 showed for the first time that major changes in the expression of a subset of genes encoding ECM components occur in adipose tissue of obese subjects and in response to weight loss. As a follow-up of these observations, picrosirius labeling of adipose tissue slides revealed that the amount of fibrosis in subcutaneous adipose tissue was increased in obesity, along with the increased inflammatory state. Pasarica et al. 62 reported that type VI collagen gene expression was elevated in obese subjects, and that obese subjects with high collagen VI displayed increased adipose tissue inflammation and increased visceral adipose tissue mass. In morbidly obese individuals, we reported the presence of different patterns of fibrous depots and detailed collagen fibers organization in the adipose tissue. 63 Macrophages of both M1 and M2
phenotype and mast cells were the main immune cells found in fibrotic areas, in which T lymphocytes were less frequent. Fibroblastic cells were also found in fibrosis. Fibrosis is typically considered a fibroproliferative disorder with the uncontrolled production of ECM components by fibroblasts activated by an inflammatory microenvironment. The pathophysiological relevance of fibrosis in the adipose tissue, which might differ between fat depots, is yet to be explored in detail.
Bariatric surgery and changes in adipose tissue genes, cells and structure further showed that accumulation of macrophages in omental adipose tissue was insufficient by itself to promote liver steatosis, although it contributed to its aggravation in conjunction with insulin resistance. By contrast, the severity of fibroinflammation was associated with higher numbers of macrophages in omental depots, irrespective of the degree of insulin resistance. This suggests that obesity-driven macrophage accumulation specifically in this adipose depot is an independent determinant of liver fibrosis and inflammatory damages. These observations support findings in humans showing that the amount of visceral fat can be associated with liver inflammation and fibrosis independent of insulin resistance. 65 Bariatric surgery has shown efficacy against morbid obesity and deleterious metabolic and cardiovascular complications. 66 Weight loss induced by bariatric surgery improves inflammatory status in obesity. In 2005, Cancello et al.
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reported that weight loss was associated with major modifications of infiltrating macrophages in subcutaneous adipose tissue. Fat-mass reduction was associated with decreased numbers of subcutaneous adipose tissue macrophages and reduction of crown-like structures in morbidly obese subjects 3 months after GBP. After weight loss, remaining macrophages stained positive for the antiinflammatory cytokine interleukin-10. The expression of chemoattractant genes (monocyte chemotactic protein-1, colonystimulating factor-3 and plasminogen activator urokinase receptor) was reduced after weight loss. These observations suggested a switch from a proinflammatory M1 phenotype toward an M2 macrophage polarization in response to weight loss. This point was reevaluated in an immunochemistry-based human study, in which the authors showed that the M1/M2 balance, estimated by the ratio of CD40 þ /CD206 þ macrophages in subcutaneous adipose tissue, decreased after weight reduction. 68 Although factors derived from M1 proinflammatory macrophages induce insulin resistance and inflammation in preadipocytes and/or adipocytes, 55, 59 it is tempting to speculate that amelioration of the M1/M2 balance toward a less proinflammatory state after weight loss contributes to the amelioration of metabolic conditions. Nevertheless, these observations might not apply to patients with smaller BMI or with diet-induced weight loss, as it was shown that shortly after calorie restriction, a transient adipose tissue inflammation might occur. 69 Finally, modifications of adipose tissue structure observed in obesity might have consequence on the outcome of weight loss. Even after bariatric surgery, there was substantial variability in individual capacity to lose fat mass. We observed in a cohort of 40 morbidly obese subjects that patients with the lower fat mass loss also had greater amount of subcutaneous fibrosis. 63 Thus, the accumulation of fibrosis might modify tissue stiffness and may hamper fat mass loss induced by surgery.
Gut microbiota change after surgery-induced weight loss
A novel factor identified to have a role in human obesity and associated metabolic risks is the commensal microbiota of the intestine or gut microbiota. The change in gut microbiota can be followed in this context. A first study conducted in three adults after Roux-en-Y GBP showed a significant decrease in Firmicutes, together with an increase in Gammaproteobacteria, using pyrosequencing. 70 But the individual fecal samples before and after weight loss were not paired.
No information was provided about the amount of weight loss and other phenotypic changes. Our team analyzed the dynamic changes post Roux-en-Y GBP in 30 morbidly obese subjects followed up for 6 months after GBP. We provided information regarding associations between gut microbiota composition, food intake, metabolic adaptations and inflammation. Whereas gut bacteria groups correlated well with energy intake, body composition and metabolic changes, other groups such as Faecalibacterium prausnitzii was correlated with changes in the inflammatory state and diabetes. The relationship between bacterial populations and obesity parameters was illustrated by the decreased proportions of Bacteroides/Prevotella in obesity and their rapid increase in proportions after surgery. 71 This is in agreement with the studies showing a lower proportion of Bacteroidetes in less obese subjects compared with lean ones (original articles reviewed in Cani and Delzenne
72
). Correlation studies using statistical models provide additional information showing that these populations of bacteria were strongly associated with body composition and metabolic parameters. After weight loss, the better the reduction in body fat mass and in circulating levels of LEP the higher the increase in the fecal proportions of Bacteroides/Prevotella. These associations were dependent on total energy intake. On the contrary, we observed that the presence of F. prausnitzii species was lower in subjects with diabetes and associated negatively with inflammatory markers before and throughout the follow-up after surgery, independently of changes in food intake. 71 This result was of particular interest as F. prausnitzii exhibits anti-inflammatory effects, partly due to secreted metabolites able to block nuclear factor kappa B activation and the secretion of proinflammatory mediators. The pathophysiological mechanisms behind these correlations should be explored in the future. In particular, mediators potentially linking the disequilibrium of gut bacterial species in obesity and the numerous features characterizing the pathological alteration of the adipose tissue remain to be identified.
Conclusion
Understanding the natural history of obesity is a critical step toward developing effective interventions for both prevention and treatment of obesity. Human obesity involves complex pathophysiological mechanisms that evolve over time and are largely beyond individual control. New environmental factors, including inner environment gut microbiota, have to be explored. Obesity complexity must be borne in mind when designing treatment strategies, considering the potential for disease progression and the heterogeneity of individuals with obesity. With the enormous difficulties that are faced by the central nervous system-functioning drugs in meeting safety recommendations, adipose tissue, inflammatory cells and gut microbiota appear to be potential targets for drug development to avoid progressive deterioration and to combat obesity and its comorbidities. 
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